Raf is well known to be involved in a broad range of cancers (Jilaveanu et al, 2009) and is considered to be an oncogene that drives the MAPK pathway and proliferation to enhance tumourigenesis (Karreth et al, 2009). The gene discussed is RAF1; the disease is cancer.